| # | Title | Journal | Year | Citations |
|---|
| 1 | Magnetite pollution nanoparticles in the human brain | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 746 |
| 2 | Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors | Frontiers in Neuroscience | 2018 | 340 |
| 3 | Drosophila male sex peptide inhibits siesta sleep and promotes locomotor activity in the post-mated female | Proceedings of the Royal Society B: Biological Sciences | 2010 | 206 |
| 4 | Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease | FASEB Journal | 2011 | 186 |
| 5 | Alpha-synuclein structure, functions, and interactions | Journal of Research in Medical Sciences | 2016 | 180 |
| 6 | TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration | Acta Neuropathologica | 2008 | 142 |
| 7 | A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease | Scientific Reports | 2013 | 142 |
| 8 | TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype | Acta Neuropathologica | 2011 | 128 |
| 9 | Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide | Nanomedicine: Nanotechnology, Biology, and Medicine | 2011 | 122 |
| 10 | Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies | Neurobiology of Disease | 2012 | 84 |
| 11 | A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease | PLoS ONE | 2013 | 76 |
| 12 | Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide | Nanomedicine: Nanotechnology, Biology, and Medicine | 2017 | 47 |
| 13 | Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ? | Schizophrenia Research | 2017 | 39 |
| 14 | Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease | Journal of Molecular Neuroscience | 2017 | 36 |
| 15 | Cell Responses to Extracellular α-Synuclein | Molecules | 2019 | 33 |
| 16 | α-Synuclein Interacts with Lipoproteins in Plasma | Journal of Molecular Neuroscience | 2017 | 32 |
| 17 | Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease | Neuroscience Letters | 2016 | 28 |
| 18 | Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity | Journal of Neurochemistry | 2018 | 27 |
| 19 | NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes | PLoS ONE | 2016 | 27 |
| 20 | Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes | Interface Focus | 2017 | 22 |
| 21 | Microbial dynamics and flagellate grazing during transition to winter in Lakes Hoare and Bonney, Antarctica | FEMS Microbiology Ecology | 2012 | 18 |
| 22 | Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin | Biochemistry | 2020 | 16 |
| 23 | Diadenosine 5′, 5′′′-P1,P4-tetraphosphate (Ap4A) is synthesized in response to DNA damage and inhibits the initiation of DNA replication | DNA Repair | 2015 | 15 |
| 24 | Amyloidosis and Longevity: A Lesson from Plants | Biology | 2019 | 9 |
